BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23377563)

  • 1. Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC).
    Blanco A; Giger-Pabst U; Solass W; Zieren J; Reymond MA
    Ann Surg Oncol; 2013 Jul; 20(7):2311-6. PubMed ID: 23377563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
    Robella M; Vaira M; De Simone M
    World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No Renal Toxicity After Repeated Treatment with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Unresectable Peritoneal Metastasis.
    Larbre V; Alyami M; Mercier F; Vantard N; Bonnefoy I; Opsomer MA; Villeneuve L; Bakrin N; Rioufol C; Glehen O; Kepenekian V
    Anticancer Res; 2018 Dec; 38(12):6869-6875. PubMed ID: 30504403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
    Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
    Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis.
    Nadiradze G; Giger-Pabst U; Zieren J; Strumberg D; Solass W; Reymond MA
    J Gastrointest Surg; 2016 Feb; 20(2):367-73. PubMed ID: 26511950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Procedure for Non-resectable Peritoneal Carcinomatosis (with Video).
    Cazauran JB; Alyami M; Lasseur A; Gybels I; Glehen O; Bakrin N
    J Gastrointest Surg; 2018 Feb; 22(2):374-375. PubMed ID: 28900843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience.
    Tempfer CB; Celik I; Solass W; Buerkle B; Pabst UG; Zieren J; Strumberg D; Reymond MA
    Gynecol Oncol; 2014 Feb; 132(2):307-11. PubMed ID: 24275155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.
    Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM
    Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects.
    Solass W; Giger-Pabst U; Zieren J; Reymond MA
    Ann Surg Oncol; 2013 Oct; 20(11):3504-11. PubMed ID: 23765417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study.
    Ellebæk SB; Graversen M; Detlefsen S; Lundell L; Fristrup CW; Pfeiffer P; Mortensen MB
    Clin Exp Metastasis; 2020 Apr; 37(2):325-332. PubMed ID: 32002724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.
    Nowacki M; Alyami M; Villeneuve L; Mercier F; Hubner M; Willaert W; Ceelen W; Reymond M; Pezet D; Arvieux C; Khomyakov V; Lay L; Gianni S; Zegarski W; Bakrin N; Glehen O
    Eur J Surg Oncol; 2018 Jul; 44(7):991-996. PubMed ID: 29526367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
    Odendahl K; Solass W; Demtröder C; Giger-Pabst U; Zieren J; Tempfer C; Reymond MA
    Eur J Surg Oncol; 2015 Oct; 41(10):1379-85. PubMed ID: 26138283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with gastric cancer and peritoneal metastasis.
    Javanbakht M; Mashayekhi A; Branagan-Harris M; Horvath P; Königsrainer A; Reymond MA; Yaghoubi M
    Eur J Surg Oncol; 2022 Jan; 48(1):188-196. PubMed ID: 34479745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Perioperative safety of intraperitoneal aerosol chemotherapy : Analysis of our first 111 pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures].
    Jansen-Winkeln B; Thieme R; Haase L; Niebisch S; Pommer C; Lyros O; Zimmer J; Lordick F; Remane Y; Frontini R; Gockel I
    Chirurg; 2019 Feb; 90(2):137-145. PubMed ID: 29947920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the "Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)", the Swiss and Austrian AGO, and the North-Eastern German Society of Gynaecologic Oncology.
    Dueckelmann AM; Fink D; Harter P; Heinzelmann V; Marth C; Mueller M; Reinthaller A; Tamussino K; Wimberger P; Sehouli J
    Arch Gynecol Obstet; 2018 Apr; 297(4):837-846. PubMed ID: 29356953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pressurized Intraperitoneal Aerosol Chemotherapy, a Palliative Treatment Approach for Patients With Peritoneal Carcinomatosis: Description of Method and Systematic Review of Literature.
    Winkler CS; Sandhu J; Pettke E; Merchea A; Fong Y; Kumara HMCS; Whelan RL
    Dis Colon Rectum; 2020 Feb; 63(2):242-255. PubMed ID: 31914116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report.
    Siebert M; Alyami M; Mercier F; Gallice C; Villeneuve L; Bérard F; Glehen O; Bakrin N; Kepenekian V
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):425-430. PubMed ID: 30511218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis.
    Di Giorgio A; Schena CA; El Halabieh MA; Abatini C; Vita E; Strippoli A; Inzani F; Rodolfino E; Romanò B; Pacelli F; Rotolo S
    Surg Oncol; 2020 Sep; 34():270-275. PubMed ID: 32891341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The scientific report from the first pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures performed in the eastern part of Central Europe.
    Nowacki M; Zegarski W
    J Int Med Res; 2018 Sep; 46(9):3748-3758. PubMed ID: 29916281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC).
    Graversen M; Detlefsen S; Bjerregaard JK; Pfeiffer P; Mortensen MB
    Clin Exp Metastasis; 2017 Jun; 34(5):309-314. PubMed ID: 28516306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.